STAT44%
Can ultrasound unlock the power of gene therapy? A startup makes big claims 93%
By Jason Mast88%
7/17/2026, 8:30:00 AM
BS Summary: This article contains 13 faulty reasoning types, including Availability Heuristic, Pessimism Bias, and Appeal to Authority, with Negativity Bias as the most egregious example at 46.8% saturation with 58 hits. Analysis detected 373 faulty-reasoning hits from 124 analyzed words, generating a BS Score of 87.4% and a BS Rank of 93% (1,700 of 21,886 articles). This article is worse (more manipulative) than 92.20% of the article peer group.
For the last year, a small California startup has been making extraordinary claims about the ability of its technology to potentially treat Duchenne muscular dystrophy — and maybe a slew of other genetic diseases, too.
The company, Sonothera, does not yet have clinical data.
But it’s presented data in animals so stunning that other experts can’t quite wrap their minds around it.
“I find it hard to believe,” said Eric Olson, molecular biology chair at UT-Southwestern Medical Center.
“It seems a bit too good to be true,” said Jeffrey Chamberlain, a longtime Duchenne gene therapy expert at the University of Washington.
To read the rest of this story subscribe to STAT+.
Speakers
2speakers31%attributed speech85writer words
Voice mapSelect a segment to jump to its words
Selected voice
100%flagged-word coverageJeffrey Chamberlain
23 attributed words59% of attributed speech100% writer coverage
Attribution is sentence-level. Pattern percentages are calculated only from words assigned to that voice.
Loading…
Loading…
Loading…
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.